Skip to product information
1 of 1

Imagine First

TESAMORELIN

TESAMORELIN

Regular price $79.00
Regular price Sale price $79.00
Sale Sold out
Shipping calculated at checkout.
Quantity

Tesamorelin is a 44-amino-acid growth hormone–releasing hormone analog studied in controlled research involving pituitary signaling and growth hormone pathways. Supplied as a clearly labeled 10 mg lyophilized research material.

Choose one vial or save 10% with a three-vial option. Variant-specific analytical documentation can be viewed through the COA section when available.

For laboratory research use only.

View full details

Research overview

A GHRH analog with downstream signaling.

Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone. Published research evaluates receptor-mediated pituitary signaling and downstream changes in growth hormone and IGF-1.

GHRHRPrimary receptor studied on pituitary somatotroph cells.
GHEndogenous pulsatile growth hormone signaling observed downstream of receptor engagement.
IGF-1A downstream biomarker evaluated in controlled clinical research.
Published nameTesamorelin
Development codeTH9507
Research classGHRH analog
Material formLyophilized powder
Compound Profile & Technical Overview
Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone, also identified in published research as TH9507. Its primary research target is the growth hormone-releasing hormone receptor (GHRHR) on pituitary somatotroph cells. Receptor engagement is studied in relation to endogenous, pulsatile growth hormone release and downstream insulin-like growth factor 1 (IGF-1) signaling. The Imagine First 10MG presentation is supplied as a lyophilized research material. Identity, analytical purity, and measured peptide content are documented separately in the current-batch Purity, ID & Quantitation report.
Storage requirements
Protect from lightKeep refrigerated after reconstitutionAvoid freeze/thaw cycles
Lyophilized powder-20°CStated stability: 24+ months
Reconstituted solution2-8°CStated stability: approximately 30 days

Sealed lyophilized vials are described as heat-stable; refrigeration or freezing of sealed vials is optional. The 2-8°C guidance applies after reconstitution. Always follow the lot-specific manufacturer documentation when it differs.

Published Research & References
Primary sources: pooled Phase 3 analysis, randomized placebo-controlled trial with safety extension, and randomized visceral- and liver-fat study. Study populations, interventions, endpoints, and limitations belong to those publications and are not claims about this research material.
Important research notice
This material is offered strictly for laboratory research use. It is not intended for human or veterinary use, food use, compounding, diagnosis, treatment, cure, or prevention of disease. Published studies of tesamorelin or approved formulations do not establish equivalence to independently supplied research material.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, FOOD, COSMETIC, OR MEDICAL PRODUCT